-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.O1.6 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Commercially Available Therapy, excluding Transplantation I

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, AML, Biological, therapy sequence, Diseases, Non-Biological, Combinations, Therapies, checkpoint inhibitors, chemotherapy, Pediatric, enzyme inhibitors, white blood cells, Technology and Procedures, Cell Lineage, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , flow cytometry
Monday, December 7, 2020: 9:00 AM-10:30 AM
Moderators:
Laura C. Michaelis, MD, The Medical College of Wisconsin Inc. and Jeffrey E. Lancet, MD, H. Lee Moffitt Cancer Ctr. & Rsrch. Institute
Disclosures:
Lancet: Abbvie: Consultancy; Agios Pharmaceuticals: Consultancy, Honoraria; Astellas Pharma: Consultancy; Celgene: Consultancy, Research Funding; Daiichi Sankyo: Consultancy; ElevateBio Management: Consultancy; Jazz Pharmaceuticals: Consultancy; Pfizer: Consultancy.
9:00 AM

Paola Minetto, MD, PhD1, Anna Candoni2*, Fabio Guolo, MD1*, Marino Clavio, MD1*, Maria Elena Zannier, MD3*, Maurizio Miglino, PhD1*, Maria Vittoria Dubbini, MD4*, Anna Sicuranza, PhD5*, Sara Ciofini5*, Elisabetta Tedone6*, Nicoletta Colombo, PhD6*, Girolamo Pugliese1*, Filippo Ballerini, MD1*, Michele Cea1*, Monica Bocchia7*, Renato Fanin, MD4* and Roberto Massimo Lemoli, MD1*

1Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
2Hematology, Azienda Sanitaria Integrata di Udine, Udine, ITA
3Division of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
4Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
5Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy
6Clinical Flow Cytometry Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
7Hematology, University of Siena, Siena, Italy

9:15 AM

Keith W. Pratz, MD1, Panayiotis Panayiotidis, MD2, Christian Recher, MD, PhD3, Xudong Wei, PhD4, Brian A Jonas, MD, PhD, FACP5, Pau Montesinos, MD, PhD6,7*, Vladimir Ivanov8*, Andre C. Schuh9, Courtney D. Dinardo, MD, MSc10, Jan Novak11*, Vlatko Pejsa, MD, PhD12*, Don A. Stevens, MD13, Su-Peng Yeh, MD14*, Inho Kim, MD, PhD15*, Mehmet Turgut, MD16*, Nicola Fracchiolla17*, Kazuhito Yamamoto, MD, PhD18, Yishai Ofran, MD19, Andrew H Wei, MBBS, PhD20, Cat Bui21*, Katy Benjamin21*, Rajesh Kamalakar, MS21*, Jalaja Potluri, MD21, Wellington Mendes21*, Jacob Devine22* and Walter Fiedler, MD23

1Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2National and Kapodistrian University of Athens Medical School, Laiko General Hospital, Athens, Greece
3Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
4The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China
5Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
6Hospital Universitario y Politécnico La Fe, Valencia, Spain
7CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
8Almazov National Medical Research Centre, Saint Petersburg, Russian Federation
9Princess Margaret Cancer Centre, Toronto, ON, Canada
10Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
11Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
12Department of Hematology, Dubrava University Hospital, Zagreb, Croatia
13Norton Cancer Institute - St Matthews Campus, Louisville, KY
14Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
15Seoul National University Hospital, Seoul, Korea, Republic of (South)
16Department of Internal Medicine, Division of Hematology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey
17Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Milan, Italy
18Aichi Cancer Center, Nagoya, Japan
19Department of Hematology and BMT Rambam Health Care Campus, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
20Australian Center for Blood Diseases, The Alfred Hospital and Monash University, Melbourne, Australia
21AbbVie Inc., North Chicago, IL
22Genentech Inc., South San Francisco, CA
23Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

9:30 AM

Danielle Hammond, MD1, Sanam Loghavi, MD2, Marina Konopleva, MD, PhD1, Tapan M. Kadia, MD3, Naval Daver, MD1, Maro Ohanian, DO1*, Ghayas C. Issa, MD1, Yesid Alvarado, MD4, Guillermo Montalban-Bravo, MD1*, Guillermo Garcia-Manero, MD1, Gautam Borthakur, MD1, Farhad Ravandi, MBBS1, Koichi Takahashi, MD, PhD1, Hagop M. Kantarjian, MD1 and Courtney D. DiNardo, MD, MSc1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX

9:45 AM

Andrew H Wei, MBBS, PhD1,2,3, Glen A Kennedy, MBBS FRACP FRCPA2,4*, Kirk L Morris, MBBA, FRACP, FRCPA2,5, Andrew Grigg, MBBS, MD, FRACP, FRCPA2,6*, Simon He, MBBS, FRACP, FRCPA2,6*, Anthony Schwarer, MBBS, MD, FRACP, FRCPA2,7*, Stephen B Ting, MBBS, FRACP, FRCPA, PhD2,7*, Anoop Kumar Enjeti, MBBS, FRCPA, FRACP, PhD, MD, MRCP2,8, Sam Yuen, MBBS, FRACP, FRCPA2,8, James D'Rozario, MBBS, FRACP, FRCPA2,9, Maya Latimer, MBBS, FRACP, FRCPA2,9*, Paula Marlton, MBBS FRACP FRCPA2,10,11, Ian Bilmon, BMBS, FRACP, FRCPA2,12*, John Taper, MBBS, FRACP, FRCPA, B Pharm2,13*, Gavin Cull, MBBS, MD, FRACP, FRCPA2,14, Campbell Tiley, MBBS, FRACP, FRCPA2,15*, Emma Verner, MBBS, FRACP, FRCPA2,16*, Uwe H Hahn, MBBS, MD, FRCPA2,17,18*, Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD2,17, Harry Iland, MBBS, FRACP, FRCPA, MHGSA2,19*, Nichloas Murphy, MBBS, FRACP, FRCPA2,20*, Sundra Ravanathan, MBBS, FRACP, FRCPA, RCPA2,21*, Uyen Nguyen2*, Doen Ming Ong, MBBS, FRACP, FRCPA, RCPA1,2*, Sun Loo, MBBS, FRACP, FRCPA, RCPA1,2*, Ing-Soo Tiong, MBBS, FRACP, FRCPA, RCPA1,2*, Meaghan Wall, MBBS, FRACP, FRCPA, RCPA, PhD2,22*, Natasha S Anstee, PhD1,2,3*, Mark Levis, MD, PhD2,23, Michael Murray, PhD, DSc2,24*, Tristan Rawling, PhD25*, Joanna Leadbetter, PhD2,26*, Ashish Bajel, FRACP2,27,28 and Andrew W Roberts, MBBS2,27,28,29,30

1The Alfred Hospital, Melbourne, Australia
2Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
3Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
4Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
5Royal Brisbane and Women's Hospital, Brisbane, Australia
6Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
7Box Hill Hospital, Melbourne, Australia
8Calvary Mater Newcastle Hospital, Sydney, Australia
9The Canberra Hospital, Canberra, Australia
10Princess Alexandra Hospital, Brisbane, Australia
11University of Queensland, Brisbane, Australia
12Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, NSW, Australia
13Nepean Hospital, Sydney, Australia
14Sir Charles Gairdner Hospital, Perth, Australia
15Gosford Hospital, Sydney, Australia
16Concord Repatriation General Hospital, Sydney, Australia
17Royal Adelaide Hospital, Adelaide, Australia
18Queen Elizabeth Hospital, Adelaide, Australia
19Royal Prince Alfred Hospital, Sydney, Australia
20Royal Hobart Hospital, Hobart, Australia
21St George Hospital, Sydney, Australia
22Murdoch Childrens Research Institute, Melbourne, Australia
23Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
24University of Sydney, Sydney, Australia
25University of Technology, Sydney, Australia
26WriteSource Medical, Sydney, Australia
27The Royal Melbourne Hospital, Melbourne, Australia
28Peter MacCallum Cancer Centre, Melbourne, Australia
29Blood Cells and Blood Cancers, Walter and Eliza Hall Institute of Medical Research, Camberwell, VIC, Australia
30University of Melbourne, Melbourne, Australia

10:00 AM

Xinxin Cao, MD1*, Ming-hui Duan, MD1*, Ai-lin Zhao1*, Hao Cai1*, Jia Chen1*, Xue-min Gao1*, Ting Liu1*, Hua-cong Cai, MD1*, Lu Zhang1*, Jian Sun, MD2*, Zhi-yong Liang, MD2*, Dao-Bin Zhou1* and Jian Li, MD1

1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

10:15 AM

Lisa Eidenschink Brodersen, PhD1, Chad A. Hudson, MD, PhD1*, Todd A. Alonzo, PhD2,3*, Robert B. Gerbing, MA2*, Laura Pardo1,4*, Amanda R. Leonti, MS5*, Timothy P. Singleton, MD1, Fan-Chi Hsu, PhD1*, Loren L. Lott1*, Fangyan Dai1*, Keely Ghiradelli1*, E. Anders Kolb, MD2,6, Todd M. Cooper, DO7, Jessica A. Pollard, MD8,9, Michael R. Loken, PhD1*, Richard Aplenc, MD, PhD10 and Soheil Meshinchi, MD, PhD2,11

1Hematologics, Inc., Seattle, WA
2Children's Oncology Group, Monrovia, CA
3Department of Preventive Medicine, University of Southern California, Monrovia, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Mountlake Terrace, WA
6Center for Cancer and Blood Disorders, Nemours Alfred I. duPont Hospital for Children, Wilmington, DE
7Seattle Children’s Hospital, Cancer and Blood Disorders Center, Seattle, WA
8Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
9Harvard Medical School, Boston, MA
10Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
11Clinical Research Division, Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA

*signifies non-member of ASH